These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 21593570)
1. Sodium butyrate improves memory function in an Alzheimer's disease mouse model when administered at an advanced stage of disease progression. Govindarajan N; Agis-Balboa RC; Walter J; Sananbenesi F; Fischer A J Alzheimers Dis; 2011; 26(1):187-97. PubMed ID: 21593570 [TBL] [Abstract][Full Text] [Related]
2. Amyloid-beta causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons. Chiba T; Yamada M; Sasabe J; Terashita K; Shimoda M; Matsuoka M; Aiso S Mol Psychiatry; 2009 Feb; 14(2):206-22. PubMed ID: 18813209 [TBL] [Abstract][Full Text] [Related]
3. Memory impairment induced by brain iron overload is accompanied by reduced H3K9 acetylation and ameliorated by sodium butyrate. Silva PF; Garcia VA; Dornelles Ada S; Silva VK; Maurmann N; Portal BC; Ferreira RD; Piazza FC; Roesler R; Schröder N Neuroscience; 2012 Jan; 200():42-9. PubMed ID: 22067609 [TBL] [Abstract][Full Text] [Related]
4. CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer's disease. Imbimbo BP; Giardino L; Sivilia S; Giuliani A; Gusciglio M; Pietrini V; Del Giudice E; D'Arrigo A; Leon A; Villetti G; Calzà L J Alzheimers Dis; 2010; 20(1):159-73. PubMed ID: 20164581 [TBL] [Abstract][Full Text] [Related]
5. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease. Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767 [TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease. He J; Luo H; Yan B; Yu Y; Wang H; Wei Z; Zhang Y; Xu H; Tempier A; Li X; Li XM Neurobiol Aging; 2009 Aug; 30(8):1205-16. PubMed ID: 18079026 [TBL] [Abstract][Full Text] [Related]
7. Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer's disease. Toledo EM; Inestrosa NC Mol Psychiatry; 2010 Mar; 15(3):272-85, 228. PubMed ID: 19621015 [TBL] [Abstract][Full Text] [Related]
8. Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an Alzheimer's disease mouse model. Ricobaraza A; Cuadrado-Tejedor M; Pérez-Mediavilla A; Frechilla D; Del Río J; García-Osta A Neuropsychopharmacology; 2009 Jun; 34(7):1721-32. PubMed ID: 19145227 [TBL] [Abstract][Full Text] [Related]
9. Indirubin-3'-monoxime rescues spatial memory deficits and attenuates beta-amyloid-associated neuropathology in a mouse model of Alzheimer's disease. Ding Y; Qiao A; Fan GH Neurobiol Dis; 2010 Aug; 39(2):156-68. PubMed ID: 20381617 [TBL] [Abstract][Full Text] [Related]
10. Early detection of memory deficits and memory improvement with vaccinia virus complement control protein in an Alzheimer's disease model. Pillay NS; Kellaway LA; Kotwal GJ Behav Brain Res; 2008 Oct; 192(2):173-7. PubMed ID: 18490064 [TBL] [Abstract][Full Text] [Related]
11. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1. Ohno M; Chang L; Tseng W; Oakley H; Citron M; Klein WL; Vassar R; Disterhoft JF Eur J Neurosci; 2006 Jan; 23(1):251-60. PubMed ID: 16420434 [TBL] [Abstract][Full Text] [Related]
12. Dose-dependent improvements in learning and memory deficits in APPPS1-21 transgenic mice treated with the orally active Aβ toxicity inhibitor SEN1500. Lo AC; Tesseur I; Scopes DI; Nerou E; Callaerts-Vegh Z; Vermaercke B; Treherne JM; De Strooper B; D'Hooge R Neuropharmacology; 2013 Dec; 75():458-66. PubMed ID: 24035915 [TBL] [Abstract][Full Text] [Related]
13. Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease mice. Arendash GW; Mori T; Cao C; Mamcarz M; Runfeldt M; Dickson A; Rezai-Zadeh K; Tane J; Citron BA; Lin X; Echeverria V; Potter H J Alzheimers Dis; 2009; 17(3):661-80. PubMed ID: 19581722 [TBL] [Abstract][Full Text] [Related]
14. Spatial learning and memory impairment and increased locomotion in a transgenic amyloid precursor protein mouse model of Alzheimer's disease. Walker JM; Fowler SW; Miller DK; Sun AY; Weisman GA; Wood WG; Sun GY; Simonyi A; Schachtman TR Behav Brain Res; 2011 Sep; 222(1):169-75. PubMed ID: 21443906 [TBL] [Abstract][Full Text] [Related]
15. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease. Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747 [TBL] [Abstract][Full Text] [Related]
16. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice. Arendash GW; Jensen MT; Salem N; Hussein N; Cracchiolo J; Dickson A; Leighty R; Potter H Neuroscience; 2007 Oct; 149(2):286-302. PubMed ID: 17904756 [TBL] [Abstract][Full Text] [Related]
17. Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern. Melnikova T; Savonenko A; Wang Q; Liang X; Hand T; Wu L; Kaufmann WE; Vehmas A; Andreasson KI Neuroscience; 2006 Sep; 141(3):1149-62. PubMed ID: 16753269 [TBL] [Abstract][Full Text] [Related]
19. Loss of HDAC5 impairs memory function: implications for Alzheimer's disease. Agis-Balboa RC; Pavelka Z; Kerimoglu C; Fischer A J Alzheimers Dis; 2013; 33(1):35-44. PubMed ID: 22914591 [TBL] [Abstract][Full Text] [Related]
20. Red mold rice ameliorates impairment of memory and learning ability in intracerebroventricular amyloid beta-infused rat by repressing amyloid beta accumulation. Lee CL; Kuo TF; Wang JJ; Pan TM J Neurosci Res; 2007 Nov; 85(14):3171-82. PubMed ID: 17663476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]